Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

NCT00418067 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2645

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Endeavor
DEVICE: Cypher
DEVICE: Taxus Liberte

Sponsor

Seung-Jung Park

Collaborators

[object Object]